Anti-cytokine therapy in fibrosing alveolitis: where are we now?

<p>Abstract</p> <p>Idiopathic pulmonary fibrosis (IPF) is a condition that has a poor prognosis, with a median survival of 4-5 years irrespective of treatment. Ziesche <it>et al</it> (<it>N Engl J Med</it> 1999, <b>341</b>: 1264-1269) describe an...

Full description

Bibliographic Details
Main Author: Millar Ann
Format: Article
Language:English
Published: BMC 2000-06-01
Series:Respiratory Research
Subjects:
Online Access:http://respiratory-research.com/content/1/1/003